ALCON INC
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 33.4
- Dividend yield
- –
About Alcon
Ophthalmic Goods, SIC 3851
Alcon develops, manufactures, and distributes eye care products through two primary divisions: Surgical and Vision Care. Its Surgical segment offers implantable intraocular lenses, surgical equipment, consumables, and diagnostic platforms for procedures treating conditions such as cataracts, glaucoma, vitreoretinal disorders, and refractive errors. The Vision Care segment supplies daily disposable, reusable, and color contact lenses, alongside ocular health remedies including dry eye solutions, allergy treatments, glaucoma therapies, and lens care items. The company serves eye care professionals, ophthalmic surgeons, clinics, and direct consumers worldwide.
The company operates across 56 countries and distributes its products to patients and consumers in over 140 countries and territories. Its global infrastructure includes 16 specialized manufacturing plants and approximately 45 interactive clinical training facilities. Corporate headquarters are situated in Geneva, Switzerland, with registered offices maintained in Fribourg, Switzerland.
Summary of the business section of Alcon's latest annual report, written by StockData.
Company profile
Company
- Legal name
- ALCON INC
- Founded
- 1945
- Headquarters
- Fort Worth, TX
- Address
- 6201 South Freeway 76134
- Phone
- (817) 293-0450
- Website
- alcon.com
- Employees
- 25,000, Dec 31, 2025
- Industry
- Ophthalmic Goods
- Incorporated in
- V8
- Fiscal year ends
- December 31
- Auditor
- PricewaterhouseCoopers LLP, Fort Worth, Texas
Stock & identifiers
- Ticker
- ALC
- Exchange
- NYSE
- Shares outstanding
- 487M, Dec 31, 2025
- Public float
- $11.61B, Dec 31, 2010
- Filer category
- Large accelerated filer
- SEC CIK
- 1167379
- EIN
- 98-0205094
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
Alcon's leadership is listed in its proxy statement (Form DEF 14A).
Employees
Headcount reported in annual reports
“We employ over 25,000 associates operating in 56 countries and serve consumers and patients in over 140 countries and territories.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Aug 5, 2025 | Merger vote | Definitive merger proxy statement |
| Apr 21, 2011 | Deregistration | Termination of SEC registration (Form 15) |
| Apr 11, 2011 | Delisting | Notice of delisting from exchange (Form 25) |
| Mar 14, 2002 | Listing | Registration of securities on an exchange (Form 8-A) |